Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial
Qamar J. Khan(University of Kansas Medical Center), Carol J. Fabian(Washington Hospital), Priyanka Sharma(Chandigarh University), Bruce F. Kimler(The University of Kansas Cancer Center), Hung‐Wen Yeh(Children's Mercy Hospital), Jennifer L. Nydegger(University of Kansas Medical Center), Pavan S. Reddy, Jennifer R. Klemp(The University of Kansas Cancer Center)
Cited by 47
Related Papers
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
American Society of Clinical Oncology Position Statement on Obesity and Cancer
|Journal of Clinical Oncology|2014|524
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
|Annals of Oncology|2022|461
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
|PubMed|2002|383
(untitled)
|Edinburgh Research Explorer|0|353